AU2001262834A1 - Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition - Google Patents
Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibitionInfo
- Publication number
- AU2001262834A1 AU2001262834A1 AU2001262834A AU6283401A AU2001262834A1 AU 2001262834 A1 AU2001262834 A1 AU 2001262834A1 AU 2001262834 A AU2001262834 A AU 2001262834A AU 6283401 A AU6283401 A AU 6283401A AU 2001262834 A1 AU2001262834 A1 AU 2001262834A1
- Authority
- AU
- Australia
- Prior art keywords
- bicalutamide
- anastrozole
- providing
- pharmaceutical combination
- aromatase inhibition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0012293.7A GB0012293D0 (en) | 2000-05-23 | 2000-05-23 | Pharmaceutical combination |
GB0012293 | 2000-05-23 | ||
PCT/SE2001/001163 WO2001089516A1 (en) | 2000-05-23 | 2001-05-22 | Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001262834A1 true AU2001262834A1 (en) | 2001-12-03 |
Family
ID=9892040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001262834A Abandoned AU2001262834A1 (en) | 2000-05-23 | 2001-05-22 | Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1292297A1 (en) |
JP (1) | JP2003534279A (en) |
AU (1) | AU2001262834A1 (en) |
GB (1) | GB0012293D0 (en) |
WO (1) | WO2001089516A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2547339T3 (en) | 2007-11-13 | 2015-10-05 | Curadis Gmbh | C-19 steroids for specific therapeutic uses |
CN102988313A (en) * | 2011-09-14 | 2013-03-27 | 北京以岭生物工程技术有限公司 | Anastrozole dispersible tablet and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3121152A1 (en) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "USE OF THE COMBINATION OF AN AROMATASE INHIBITOR WITH AN ANTIANDROGEN FOR PROPHYLAXIS AND THERAPY OF PROSTATE HYPERPLASIA" |
ATE28864T1 (en) * | 1982-07-23 | 1987-08-15 | Ici Plc | AMIDE DERIVATIVES. |
GB8714013D0 (en) * | 1987-06-16 | 1987-07-22 | Ici Plc | (substituted-aralkyl)heterocyclic compounds |
US4895715A (en) * | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
EP0748220A4 (en) * | 1994-01-21 | 1997-09-10 | Sepracor Inc | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
GB9930839D0 (en) * | 1999-12-30 | 2000-02-16 | Pharmacia & Upjohn Spa | Process for treating gynecomastia |
-
2000
- 2000-05-23 GB GBGB0012293.7A patent/GB0012293D0/en not_active Ceased
-
2001
- 2001-05-22 EP EP01937066A patent/EP1292297A1/en not_active Withdrawn
- 2001-05-22 JP JP2001585760A patent/JP2003534279A/en active Pending
- 2001-05-22 WO PCT/SE2001/001163 patent/WO2001089516A1/en not_active Application Discontinuation
- 2001-05-22 AU AU2001262834A patent/AU2001262834A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001089516A1 (en) | 2001-11-29 |
JP2003534279A (en) | 2003-11-18 |
GB0012293D0 (en) | 2000-07-12 |
EP1292297A1 (en) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1085848A4 (en) | Inhibitors of transcription factor nf-kappa b | |
HUP0201463A3 (en) | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and their use | |
PL370447A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
SI1423381T1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
AU4166400A (en) | Alkenyl and alkynyl compounds as inhibitors of factor xa | |
EP1383743A4 (en) | Dual inhibitors of pde 7 and pde 4 | |
HUP0201872A2 (en) | Steroid compounds and pharmaceutical compositions of the same | |
AU2002235520A1 (en) | Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer | |
AU2001269314A1 (en) | Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds | |
AU2003223601A1 (en) | ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4 | |
AU2001273074A1 (en) | Combinations of ssri and estrogenic agents | |
AU2001271163A1 (en) | Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition | |
AU2001228703A1 (en) | Use of cox-2 inhibitors for the treatment of constipation | |
AU2001288682A1 (en) | Inhibition of cmv infection and dissemination | |
HUP0401687A3 (en) | Acylsulfonamides as inhibitors of steroid sulfatase and pharmaceutical compositions containing them | |
IL140324A0 (en) | Inhibition of transcription factor nf-kb | |
HK1053061A1 (en) | Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect | |
AU2001262834A1 (en) | Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition | |
AUPQ629000A0 (en) | Inhibition of fungi | |
AU7601400A (en) | Treatment and prevention of hepatic disorders | |
AU5673099A (en) | Inhibitors of amyloid formation | |
AU3663700A (en) | Association of no-synthase inhibitor(s) and metabolic antioxidant(s) | |
AU2001268000A1 (en) | Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition | |
AU2001268001A1 (en) | Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition | |
AU2001271162A1 (en) | Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition |